Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Researchers at Columbia University have developed a machine learning algorithm that identifies and predicts gender-based differences in adverse reactions to drugs.
A supplier of healthcare software in the respiratory care space has received the FDA’s blessing to market deep learning elements newly added to an existing product.
The work of Regina Barzilay, PhD, a professor of electrical engineering and computer science at MIT, has focused on breast imaging, the development of new antibiotics and much more.
A small but mighty research outfit based in Hungary has compiled a user-friendly database of medical technologies anchored in AI and approved by the FDA.
The novel AI-aided app can run on both Apple and Android operating systems and only needs to be placed near the would-be sleeper—a familiar nightstand, shelf or end table will do—at bedtime.
Researchers at West Virginia University are well placed to tap AI for teasing out the role of existing respiratory concerns in the progression of COVID-19.
